{"version":"1.0","type":"link","title":"Effectiveness of primary tumor resection for survival after first-line cetuximab or bevacizumab in KRAS wild-type metastatic colorectal cancer treated with subsequent trifluridine/tipiracil or regorafenib.","author_name":"Chen YH 외","author_url":"https://prs-insight.online/author/Chen%20YH","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/106546","thumbnail_width":1200,"thumbnail_height":630}